相关实验视频

Updated: Sep 17, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

在移植后对外围白细胞亚型和延迟移植功能的量化:单一中心分析

Jingyi Zhou¹, Meifang Wang¹, Hao Deng¹

¹Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China; National Key Clinical Department of Kidney Diseases, Hangzhou, China; Institute of Nephrology, Zhejiang University, Hangzhou, China; The Third Grade Laboratory Under the National State, Administration of Traditional Chinese Medicine, Hangzhou, China.

Transplantation proceedings

|July 1, 2025

概括

在移植后对白细胞 (WBC) 亚型的早期分析可以预测延迟移植功能 (DGF) 和患者的结果. 监测辅助和细胞毒性T细胞为DCD移植接受者提供了宝贵的预后见解.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
免疫学免疫学免疫学
移植科学移植科学

背景情况:

延迟移植功能 (DGF) 是从循环死亡 (DCD) 后的捐赠者捐赠移植的一个重要并发症.
免疫学因素在DGF的发展中起着至关重要的作用.
预测DGF及其对移植结果的影响对于优化患者管理至关重要.

研究的目的:

调查外围白细胞 (WBC) 亚型的早期术后量化对DGF发病的预测价值.
评估DCD脏移植接受者中WBC亚型和DGF结果之间的关联.
评估诱导治疗对这些关联的影响.

主要方法:

对217名DCD移植接受者的回顾性分析.
在术后第一天通过流细胞计量对外围白细胞亚型 (包括T细胞亚组) 的量化.
使用后勤回归和接收器运行特征 (ROC) 曲线进行统计分析.

主要成果:

16.13%的接受者发展了DGF,与较高的血清肌素和增加的移植损失有关.
在术后第一天较低的辅助T细胞 (CD3+CD4+) 比率预测了DGF发病 (AUC = 0.893).
在DGF患者中,细胞毒性T细胞 (CD3+CD8+) 比率升高与较差的结局相关.
巴西西西马布诱导保留了亚型关联,而抗细胞球蛋白 (ATG) 取消了它们.

结论:

早期的术后WBC亚型定量,特别是T细胞亚组,为DGF及其结果提供预后信息.
常规的免疫监测可以帮助DCD移植接受者的临床管理决策.
需要进一步的研究来阐明机制和治疗策略.

更多相关视频

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

相关概念视频

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...